Abstract
A comparison was made of the ability of phenolic phenethylamines and their O-methyl congeners to deplete both prelabeled cardiac H3-norepinephrine and endogenous norepinephrine stores in the mouse. O-methyl derivatives were inactive with the notable exception of 3,5-dihydroxy-4-methoxyphenethylamine, which proved to be an effective releasing agent. The ED50 of this amine, the β-hydroxylated analog and 3,4,5-trihydroxyphenethylamine was determined and compared to reserpine, l-metaraminol, 6-OH dopamine and tyramine. The effects of cocaine and bretylium on the release of norepinephrine induced by these trioxy amines were determined. The metabolism of H3-norepinephrine in the isolated perfused rat heart during release with 3,5-dihydroxy-4-methoxyphenethylamine was compared to the metabolism obtained with reserpine and tyramine perfusion. A shift toward metabolism by monoamine oxidase was observed and a marked increase in the release of free catecholamine. Evidence is presented showing that 3, 5-dihydroxy-4-methoxyphenethylamine was taken up by the heart and converted to the β-hydroxylated analog in vivo; also, this amine was shown to be a substrate for dopamine-β hydroxylase in vitro.
Footnotes
- Received March 16, 1967.
- Accepted June 1, 1967.
- © 1967 by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|